Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies

NCT04033159 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
14
Enrollment
INDUSTRY
Sponsor class

Stopped Based on tolerability findings at the low dose level thus far, continuation of dosing or even dose escalation is not possible.

Conditions

Interventions

Sponsor

Dynacure